Liron Walsh

Nephrology
201 Lyons Ave
Newark, NJ 07112

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy.

Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy.

Journal: The New England journal of medicine
Published: September 26, 2025

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy.

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy.

Journal: The New England journal of medicine
Published: November 18, 2024

Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.

Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: May 29, 2024

Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome.

Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome.

Journal: Glomerular diseases
Published: January 11, 2022

Health-Related Quality of Life in Focal Segmental Glomerular Sclerosis and Minimal Change Disease: A Qualitative Study of Children and Adults to Inform Patient-Reported Outcomes.

Health-Related Quality of Life in Focal Segmental Glomerular Sclerosis and Minimal Change Disease: A Qualitative Study of Children and Adults to Inform Patient-Reported Outcomes.

Journal: Kidney medicine
Published: August 17, 2021

Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design.

Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design.

Journal: Kidney international reports
Published: April 12, 2021

Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.

Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: September 06, 2019

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.

Journal: The New England journal of medicine
Published: December 12, 2017

Estimating the Effect of Preventable Treatment Discontinuation on Health Outcomes.

Estimating the Effect of Preventable Treatment Discontinuation on Health Outcomes.

Journal: Epidemiology (Cambridge, Mass.)
Published: October 10, 2017

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.

Journal: JAMA
Published: January 18, 2017

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.

Journal: Orphanet journal of rare diseases
Published: December 07, 2016

Current unmet needs in renal transplantation: a review of challenges and therapeutics.

Current unmet needs in renal transplantation: a review of challenges and therapeutics.

Journal: Frontiers in bioscience (Elite edition)
Published: December 29, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026